With sales of potential blockbuster Lokelma scaling up, AstraZeneca is bolstering its production of the hyperkalemia treatment with a $445 million injection of funds. The investment will increase the capabilities of AZ’s manufacturing facility in Coppell, Texas, which is the company’s lone site in the world that produces Lokelma.
AstraZeneca to spend $445M to boost production of Lokelma at Texas plant
Latest from Blog
Dr. Maya Rosman with the summer fruit that is excellent for weight loss
In the summer everyone gets excited about grapes and watermelon – but the truth is that plums are not only no less tasty – but they are also very healthy for you.
Danone To Acquire MADE Group To Expand Healthy Nutrition Business In Asia Pacific
Danone announced that it entered into two definitive agreements to expand its presence in the fast-growing healthy nutrition market across the Asia-Pacific region. Post Views: 2
BinSentry and Trouw Nutrition Canada expand partnership
AI-driven feed inventory platform will now be deployed across Trouw’s entire Canadian network. Post Views: 2
INTRODUCING: Juice Plus+ Complete Strawberry Nutrition Shake
/PRNewswire/ — Juice Plus+, the leader in global nutrition for more than 30 years, introduces Complete Strawberry Nutrition Shake, a delicious shake mix… Post Views: 2
Inner Haven Wellness Brings Plate-by-Plate Nutrition Approach to Eating Disorder Care, Helping Clients Build Confidence Beyond Treatment
/PRNewswire/ — Inner Haven Wellness, a specialized eating disorder treatment provider offering Partial Hospitalization Program (PHP) and Intensive Outpatient… Post Views: 2